6/25/2026 3:39:37 PM From Science to Signals: SEC Enforcement, Predictive Markets, and Informational Advantage in Life Sciences By Melissa Hodgman Timothy Howard Nicholas Caselli SEC enforcement in the life sciences sector has not simply intensified—it has fundamentally changed in character. What regulators are...
6/8/2026 1:40:37 PM China Biotech Deals Are in the U.S. Congress’ Crosshairs: Here’s What Life Sciences Companies Need to Know By Andrew Dockham Jeff Jay Kristen Riemenschneider Jake Silvers Loren Terry +2 more... Show less The U.S. biotech industry is at an inflection point. As U.S. pharma companies have increasingly turned to Chinese biotech firms to...
5/18/2026 4:44:07 PM Companion Diagnostics: Key Trends Shaping Negotiations By Zackory Burns Introduction Companion diagnostics (“CDx”) are medical devices which provide information that is essential for the safe and effective use...
4/7/2026 5:49:54 PM Life Sciences Round Up - Q1 2026 By Kristen Riemenschneider Madeleine Tavcar The first quarter of 2026 has been anything but quiet in the life sciences sector. Here are the top issues and trends we’ve noticed in...
3/25/2026 1:52:39 PM Tariffs, Trade, and Dealmaking: Emerging Risks for Life Sciences Companies By Eric Bruce Kristen Riemenschneider Nabeel Yousef Stephanie Brown Cripps Justin Simeone Jake Silvers Ian Allen +4 more... Show less The past year has proven tumultuous for life sciences companies, whose pharmaceutical products, active ingredients, and medical devices...
2/13/2026 8:52:43 PM Key Drivers for the FTC’s First Merger Victory of the Second Trump Administration By Meghan Rissmiller Andrew Ewalt Julie Elmer Constance Forkner Sam Fulliton Chris Kraft Kara Reid Gabriella Small +5 more... Show less Edwards Lifesciences Corp. (Edwards) abandoned its $945 million acquisition of JenaValve Technology, Inc. (JenaValve) after the U.S....
2/5/2026 6:25:31 PM Life Sciences Enforcement Testing the Boundaries of Competition Law By Kaylynn Moss Sean Norick Long Toyosi Taiwo Lucas Vanassche +1 more... Show less Life sciences is a high-stakes sector where antitrust enforcement is testing the boundaries of competition law. The focus differs sharply...
1/21/2026 8:25:32 PM 10 Key MedTech Themes for 2026 By Vinita Kailasanath Kayla Weston Yungjee Kim Shannon O'Hara +1 more... Show less The MedTech industry is entering 2026 at a pivotal moment. Regulatory complexities, geopolitical tensions, and persistent supply chain...
1/20/2026 8:27:32 PM 2026 J.P. Morgan Healthcare Conference Highlights By Jeff Jay Vinita Kailasanath Madeleine Tavcar Wolfgang Paulson Kayla Weston +2 more... Show less The 44th Annual J.P. Morgan Healthcare Conference concluded last week in San Francisco. In general, we noted a cautiously optimistic...
9/12/2025 1:53:40 PM Novel Considerations in Licensing Deals with Chinese Biotechs By Kristen Riemenschneider Ya Ma Shannon O'Hara Jake Silvers Yichen Xing +2 more... Show less Significant Chinese investment in its biotechnology industry has resulted in a shift in the biopharma licensing market over the last five...
9/11/2025 7:03:58 PM BIOSECURE Act: 2025 Version By Andrew Dockham Austin Evers Kristen Riemenschneider Shannon O'Hara Madeline Cimino +2 more... Show less The BIOSECURE Act, first introduced in Congress last year, has now been reintroduced for inclusion in Senate’s draft of the annual...
8/29/2025 1:48:15 PM Structuring Non-competes in License and Collaboration Agreements By Jeff Jay As big pharmas and other commercial-stage biopharma and biotech companies grapple with the reality of patent cliffs on the horizon, which...
1/27/2025 7:48:38 PM Life sciences – what to watch in 2025 By Adam Golden Kristen Riemenschneider Madeleine Tavcar We asked more than 200 Freshfields lawyers – across geographies and practice areas: what are the 1-2 issues top of mind for you and your...
9/18/2024 2:00:34 PM Post-Patent Expiry Royalties for Research Collaborations and Licenses: The Third Circuit Weighs in on Brulotte By Adam Golden Kristen Riemenschneider Jeff Jay Jake Silvers Dylan O'Connor +2 more... Show less According to settled Supreme Court case law, the holder of a patent may not require a licensee to pay royalties after the patent...
6/24/2024 6:20:12 PM FTC Comments on USPTO’s Notice of Proposed Rulemaking Involving Patent Settlement Agreements By Vinita Kailasanath Justin Stewart-Teitelbaum Laura Onken Jake Silvers +1 more... Show less On June 18, 2024, the Federal Trade Commission (FTC) issued a comment (the FTC Comment) responding to the United States Patent and...
6/10/2024 7:42:45 PM Will NIH’s Newly-Proposed Policy Improve Patient Access? By Jeff Jay Shannon O'Hara On May 22, 2024, the U.S. National Institutes of Health (NIH) announced it was soliciting feedback on a proposed policy (the Policy)1...